kcmolinaID Profile Banner
Kyle C. Molina Profile
Kyle C. Molina

@kcmolinaID

Followers
458
Following
446
Media
7
Statuses
115

ID Pharmacist

San Diego
Joined February 2017
Don't wanna be here? Send us removal request.
@kcmolinaID
Kyle C. Molina
4 days
RT @andhen25: We partnered with Colombian scientists to discuss control strategies and future directions of the ongoing #Yellowfever outbre….
Tweet card summary image
journals.sagepub.com
0
4
0
@kcmolinaID
Kyle C. Molina
14 days
Proud to see our Mandells PPID chapter on the antibiotic pipeline published. A huge career bucket list item for me since I started in ID. Special thanks to my collaborators: our editor @yohei_doi and co-authors @MattMil81732351 and Gerry Barber.
Tweet media one
1
2
26
@kcmolinaID
Kyle C. Molina
3 months
RT @ThoPham27: 🚨Exciting ID #Fellowship Alert🚨. MWU COP-Glendale is recruiting for a fellow to start this July 2025. An excellent opportuni….
0
2
0
@kcmolinaID
Kyle C. Molina
10 months
Excited to be presenting at CSHP on October 31st at 1pm to provide updates on the role of long-acting lipoglycopeptides, Oritavancin and Dalbavancin.
Tweet media one
2
1
15
@kcmolinaID
Kyle C. Molina
11 months
Really proud to share our work exploring a machine learning approach for allocation of COVID mabs during resource scarcity. Led by the brilliant Mengli Xiao and @AditGinde as part of @mab_colorado. @CUAnschutz.
@JAMAHealthForum
JAMA Health Forum
11 months
This retrospective cohort study using data from an EHR platform of nonhospitalized patients with COVID-19 found that policy learning tree-based allocation resulted in greater risk reductions in hospitalization than other point scoring systems. @kcmolinaID
Tweet media one
0
2
11
@kcmolinaID
Kyle C. Molina
1 year
Interesting look at CMV Retinitis in SOT led by @SiasScherger at @UNMC_ID! .
0
1
4
@kcmolinaID
Kyle C. Molina
1 year
RT @GabyFrankMD: Great video by expert Dr. Barron. Check it out. @CUDivofID @CUInternalMed @CUDivHospMed @TheNETEC.
0
2
0
@kcmolinaID
Kyle C. Molina
1 year
RT @SIDPharm: See you all tomorrow at 12-1pm EST right here, to share your experience as & with ID Pharmacists and how you fight Antimicrob….
0
4
0
@kcmolinaID
Kyle C. Molina
1 year
RT @realMickCass: Honorary Greatest Briton going to Richard Grenell, openly gay former cabinet member in President Trump’s Administration.….
0
27
0
@kcmolinaID
Kyle C. Molina
1 year
Dalbavancin non-inferior to SOC in complicated SAB. Big spoiler for the highly anticipated DOTS trial. Can't wait to see these data presented next week! @ECCMID2024 @ABsteward
Tweet media one
3
21
116
@kcmolinaID
Kyle C. Molina
2 years
RT @MightKnot: Substance use disorder-associated infections’ treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) – an in….
0
2
0
@kcmolinaID
Kyle C. Molina
2 years
RT @ABsteward: Each hour until antibiotics increases mortality in sepsis?.🆕️🔥In a fully adjusted model of patients treated within 6 h, each….
Tweet card summary image
academic.oup.com
We document how common analytic choices to characterize associations between time-to-antibiotics and mortality for suspected sepsis can generate misleading
0
87
0
@kcmolinaID
Kyle C. Molina
2 years
Big shoutout to @AbidiMaheen for leading this important work evaluating CMV immune reconstitution in cord blood transplant recipients! .
1
0
6
@kcmolinaID
Kyle C. Molina
2 years
RT @DanyaRoshdy: 🚨2nd of 3 Medical Minutes on ABSSSI now available! Join @kcmolinaID to learn how to optimize treatment and incorporate lon….
0
2
0
@kcmolinaID
Kyle C. Molina
2 years
Huge shoutout to @DanyaRoshdy for the incredible work she did on this!.
0
0
2
@kcmolinaID
Kyle C. Molina
2 years
Fantastic information about the diagnosis of ABSSSI from the LaLGP expert @MightKnot - the first in our 3 part CE reviewing use of the role of DAL/ORI for ABSSSI @SIDPharm @CCO_Education .
Tweet card summary image
clinicaloptions.com
In this case-based discussion, learn about the prevalence and impact of skin and soft tissue infections, differences in clinical presentation and etiology between purulent and nonpurulent infections,...
1
3
9
@kcmolinaID
Kyle C. Molina
2 years
Another @mab_colorado work confirming effectiveness of bebtelovimab during Omicron. Important to correlate in vitro neutralization data to clinical outcomes with changing COVID variants. @AditGinde .@NicholeBiostats @neil_aggarwal .
0
1
12
@kcmolinaID
Kyle C. Molina
2 years
RT @BethanyKwan: Thanks for including insights from the @mab_colorado project in this article about the need for Dissemination and Implemen….
0
1
0
@kcmolinaID
Kyle C. Molina
2 years
RT @JAMA_current: The growing field of implementation science aims to close the years’ long gap between the development of medical interven….
0
25
0